FindTrial
Sign In

Multi-protein Assessment using Serum to deTermine the breast lesion malignancy: a prospective multicenter trial ; MAST trial

Multi-protein Assessment using Serum to deTermine the breast lesion malignancy: a prospective multicenter trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004847
Enrollment
677
Registered
2020-03-20
Start date
2019-08-28
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Bertis Healthcare
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: -Patients with lesions of BI-RADS category C4b or higher identified through mammography or ultrasound. -Women over 19 Patients with no history of other cancers, including breast cancer Patients who voluntarily decided to participate in this clinical study and signed written informed consent Patients in BI-RADS category C1-2

Exclusion criteria

Exclusion criteria: -Patients with recurrent breast cancer Patients diagnosed with cancer in other organs within 5 years -Patients with other cancers identified by metastases -General condition that prevents you from understanding and submitting consent

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity—

Secondary

MeasureTime frame
Predictive values;Positive predictive values;Negative predictive values;Accuracy—

Countries

Korea, Republic of

Contacts

Public ContactEun-Shin Lee

Seoul National University Healthcare System Gangnam Center

silvershoe99@gmail.com+82-2-2002-5682

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 12, 2026